VeritaCell is a brand consisting of a team of passionate entrepreneurs and cell biology experts dedicated to improving the well-being of patients worldwide. The team was formed in Riga, Latvia in 2018 through a matchmaking session by Commercialization Reactor, a platform that connects inventors of breakthrough technologies with entrepreneurs looking to commercialize them. The team's vision is to simplify and enhance wound healing, inspired by a personal motive of one team member who had a relative with a complex, slow-healing wound.

They aim to develop a product that will make a significant impact on patients in similar situations. The team includes individuals with diverse expertise, such as business and economics, biochemistry and molecular biology, and international business development. With two years of extensive research and industry networking, VeritaCell has validated the need for their product in the wound care market.

They have established crucial contacts within the industry and formed an experienced advisory board. The brand is committed to creating impactful solutions for patients and plans to launch their product in Europe in 2022. Their goal is to provide the simplest surgical solution that promotes faster recovery, scar-free healing, and cost savings for hospitals